Abstract: A light masking system for a vehicle includes: a printed circuit board (PCB); at least one infrared (IR) light source disposed on a first surface of the PCB and configured to emit a first predetermined wavelength range of light; at least one masking light source disposed on the first surface of the PCB proximal to the IR light source and configured to emit a second predetermined wavelength range of light, wherein a portion of the emitted first predetermined wavelength range of light of the IR light source includes visible light; and the emitted second predetermined wavelength range of light of the at least one masking light source masks the emitted visible light from the first predetermined wavelength range of the at least one IR light source.

Abstract: A light masking system for a vehicle includes: a printed circuit board (PCB); at least one infrared (IR) light source disposed on a first surface of the PCB and configured to emit a first predetermined wavelength range of light; at least one masking light source disposed on the first surface of the PCB proximal to the IR light source and configured to emit a second predetermined wavelength range of light, wherein a portion of the emitted first predetermined wavelength range of light of the IR light source includes visible light; and the emitted second predetermined wavelength range of light of the at least one masking light source masks the emitted visible light from the first predetermined wavelength range of the at least one IR light source.

Abstract: A light masking system for a vehicle includes: a printed circuit board (PCB); at least one infrared (IR) light source disposed on a first surface of the PCB and configured to emit a first predetermined wavelength range of light; at least one masking light source disposed on the first surface of the PCB proximal to the IR light source and configured to emit a second predetermined wavelength range of light, wherein a portion of the emitted first predetermined wavelength range of light of the IR light source includes visible light; and the emitted second predetermined wavelength range of light of the at least one masking light source masks the emitted visible light from the first predetermined wavelength range of the at least one IR light source.

Abstract: Disclosed are methods and systems for a computing environment that allows an operator to maximize or increase compliance with one or more data and privacy standards. In one embodiment, compliant and non-compliant sources are identified and exchange of data between those sources are blocked, partially allowed or allowed with regulation-compliant encryption of data.

Abstract: A light masking system for a vehicle includes: a printed circuit board (PCB); at least one infrared (IR) light source disposed on a first surface of the PCB and configured to emit a first predetermined wavelength range of light; at least one masking light source disposed on the first surface of the PCB proximal to the IR light source and configured to emit a second predetermined wavelength range of light, wherein a portion of the emitted first predetermined wavelength range of light of the IR light source includes visible light; and the emitted second predetermined wavelength range of light of the at least one masking light source masks the emitted visible light from the first predetermined wavelength range of the at least one IR light source.

Abstract: A light system comprising: (a) a light source that is configured to direct light from an exterior of a vehicle; and (b) two or more optical elements that direct the light to two or more desired locations without movement of the light source, the two or more optical elements being in series so that the light from the light source is directed through the two or more optical elements; and wherein the two or more desired locations include a driving surface and a location above the driving surface.

Abstract: Described herein are methods for modulation of the activity of the carotid body that afford therapeutic benefit for sleep-related breathing disorders and related conditions.

Abstract: A compact digital camera and infrared (IR) illuminator apparatus, including IR illuminators arranged adjacent to the digital camera. The digital camera has a camera lens and each IR illuminator includes IR LEDs. A single cover lens is positioned to cover the at least one IR LED and the camera lens. A region of the single cover lens that covers the IR LEDs blocks visible light and a region of the single cover lens that covers the camera lens is a neutral lens that transmits visible light. The single cover lens is a two-shot molded lens or a three-shot molded lens.

Abstract: A compact digital camera and infrared (IR) illuminator apparatus, including IR illuminators arranged adjacent to the digital camera. The digital camera has a camera lens and each IR illuminator includes IR LEDs. A single cover lens is positioned to cover the at least one IR LED and the camera lens. A region of the single cover lens that covers the IR LEDs blocks visible light and a region of the single cover lens that covers the camera lens is a neutral lens that transmits visible light. The single cover lens is a two-shot molded lens or a three-shot molded lens.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-?-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-?-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-?-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-?-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-?-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

Abstract: Described are methods of treatment of cutaneous injuries or conditions comprising administration of CSE inhibitors to individuals in need thereof. Also described herein are methods of treatment of sleep-related breathing disorders comprising administration of CSE inhibitors to individuals in need thereof.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-?-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit cystathionine-?-lyase (CSE). Also described herein are methods for using such CSE inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from CSE inhibition.

Abstract: Financial advisory methods and systems for creating a steady lifetime income stream within an investment plan is provided. According to one embodiment, a feasible, personalized pattern of periodic cash payouts from an investment plan is structured to achieve level annual income during a payout period when combined with other income sources. A mapping is maintained of fixed income investments from a limited universe of financial products available within the investment plan to corresponding constant maturity Treasury bond (CMT) weights. Based on the mapping, a payout program is designed that is expected to generate a stream of income sufficient to fund the cash payouts by determining an appropriate allocation of assets within the investment plan among the fixed income investments. A payout portfolio is formed within the investment plan including holdings in the fixed income investments in accordance with the determined appropriate allocation. The cash payouts are paid to the investor.

Abstract: Financial advisory methods and systems for creating a steady lifetime income stream within an investment plan is provided. According to one embodiment, based on an investor's current holdings in the investment plan, a pattern of periodic cash payouts is identified that can be made to the investor from an in-plan payout program implemented with the limited universe of financial products available within the investment plan. The assets of the investment plan are rebalanced to form a payout portfolio and an equity exposure portfolio. The payout portfolio is constructed to create an annuity-like stream of income to support the pattern of periodic cash payouts and includes multiple bond funds. The equity exposure portfolio is constructed to address inflation risk by providing an ability to rise with equities markets. Finally, a periodic cash payout of the pattern of periodic cash payouts is caused to be paid to the investor from the investment plan.

Abstract: Financial advisory methods and systems for creating a steady lifetime income stream within an investment plan is provided. According to one embodiment, based on an investor's current holdings in the investment plan, a pattern of periodic cash payouts is identified that can be made to the investor from an in-plan payout program implemented with the limited universe of financial products available within the investment plan. The assets of the investment plan are rebalanced to form a payout portfolio and an equity exposure portfolio. The payout portfolio is constructed to create an annuity-like stream of income to support the pattern of periodic cash payouts and includes multiple bond funds. The equity exposure portfolio is constructed to address inflation risk by providing an ability to rise with equities markets. Finally, a periodic cash payout of the pattern of periodic cash payouts is caused to be paid to the investor from the investment plan.